David Johnson
2021 - Global Blood Therapeutics
In 2021, David Johnson earned a total compensation of $2.7M as Chief Commercial Officer at Global Blood Therapeutics, a 57% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $178,000 |
|---|---|
| Option Awards | $1,102,132 |
| Salary | $477,500 |
| Stock Awards | $983,097 |
| Other | $6,000 |
| Total | $2,746,729 |
Johnson received $1.1M in option awards, accounting for 40% of the total pay in 2021.
Johnson also received $178K in non-equity incentive plan, $477.5K in salary, $983.1K in stock awards and $6K in other compensation.
Rankings
In 2021, David Johnson's compensation ranked 4,778th out of 12,406 executives tracked by ExecPay. In other words, Johnson earned more than 61.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,778 out of 12,406 | 62nd |
Division Manufacturing | 1,991 out of 5,492 | 64th |
Major group Chemicals And Allied Products | 840 out of 2,368 | 65th |
Industry group Drugs | 752 out of 2,089 | 64th |
Industry Pharmaceutical Preparations | 538 out of 1,536 | 65th |
Pay ratio
| David Johnson's Pay | $2,746,729 |
|---|---|
| Median Employee's Pay | $345,973 |
| Pay Ratio | 8to 1 |
In 2021, the annual total compensation of David Johnson was $2,746,729.
The annual total compensation of the median employee at Global Blood Therapeutics was $345,973.
The ratio of David Johnson's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on April 28, 2022.
Johnson's colleagues
We found four more compensation records of executives who worked with David Johnson at Global Blood Therapeutics in 2021.